Despite partial suppression of NRF2 signaling in the combination group, overall tumor cell death was significantly enhanced, likely due to elevated oxidative stress.

Ayomide Akomolafe, a PhD student from Ekiti State, Nigeria, studying in the United States, has amazed the medical world with a new discovery that could help treat glioblastoma the most dangerous type ...